CLB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Core Laboratories's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $0.0 Mil.
Core Laboratories's quarterly Other Stockholders Equity stayed the same from Mar. 2024 ($0.0 Mil) to Jun. 2024 ($0.0 Mil) but then declined from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil).
Core Laboratories's annual Other Stockholders Equity stayed the same from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($0.0 Mil) but then increased from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil).
The historical data trend for Core Laboratories's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Core Laboratories Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity
Thank you for viewing the detailed overview of Core Laboratories's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Katherine Murray | director | 6316 WINDFERN ROAD, HOUSTON TX 77040 |
Mark Damian Tattoli | officer: SVP, Gen Counsel & Secretary | C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040 |
Kwaku Temeng | director | C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002 |
Gwendolyn Schreffler | officer: SVP | C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040 |
Harvey Robert Klingensmith | director | P.O. BOX 131144, HOUSTON TX 77219-1114 |
Van Dijken Eeuwijk Monique | director | P.O. BOX 129, BILTHOVEN P7 3720 AC |
Jan Willem Sodderland | director | DUINDISTEL 89, NOORDWIJK P7 2202 DE |
Goldman Sachs Group Inc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Goldman Sachs & Co. Llc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Lawrence Bruno | officer: President | 6316 WINDFERN ROAD, HOUSTON TX 77040 |
Mark F Elvig | officer: VP, Counsel & Secretary | 6316 WINDFERN, HOUSTON TX 77040 |
Gregory Barry Barnett | director | 853 MILWAUKEE STREET, DENVER CO 80206 |
Kevin Daniels | officer: CAO & Treasurer | 6316 WINDFERN ROAD, HOUSTON TX 77040 |
Michael Straughen | director | 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN |
Martha Z. Carnes | director | 6316 WINDFERN ROAD, HOUSTON TX 77040 |
From GuruFocus
By PRNewswire • 10-02-2023
By GuruFocus News • 10-24-2024
By PRNewswire PRNewswire • 03-27-2023
By PRNewswire • 10-09-2023
By GuruFocus Research • 02-10-2024
By GuruFocus News • 10-22-2024
By PRNewswire • 07-24-2024
By PRNewswire • 07-26-2023
By GuruFocus News • 10-25-2024
By PRNewswire • 03-25-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.